[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335914-105":59,"doc-detail-335914-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oraov1-ccnd1-and-mir548k-are-the-driver-oncogenes-of-the-11q13-amplicon-in-squamous-cell-carcinoma","ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma","","11q13 amplification is a frequent event in human cancer and in particular in squamous cell carcinomas (SCC). Using computational, in vitro, ex vivo, and in vivo models with efficient primary human keratinocyte genome editing by Cas9-RNP electroporation, the study identifies ORAOV1, CCND1, and MIR548K as critical drivers of the 11q13 amplicon in head and neck SCC. CCND1 amplification promotes cell-cycle control independently of CDK4/6 and RB1, with potential RRM2 dependency. MIR548K supports epithelial–mesenchymal transition, while ORAOV1 likely acts through modulation of reactive oxygen species, yielding at least three independent genetic mechanisms and therapeutic targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oraov1-ccnd1-and-mir548k-are-the-driver-oncogenes-of-the-11q13-amplicon-in-squamous-cell-carcinoma/335914/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oraov1-ccnd1-and-mir548k-are-the-driver-oncogenes-of-the-11q13-amplicon-in-squamous-cell-carcinoma/335914.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What event in cancer is emphasized in the study, and where is it common?","Question",{"text":112,"@type":113},"The study focuses on 11q13 amplification, described as a frequent cancer event and particularly common in squamous cell carcinomas (SCC), including head and neck SCC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which genes are identified as the critical driver oncogenes of the 11q13 amplicon?",{"text":117,"@type":113},"The study identifies ORAOV1, CCND1, and MIR548K as the critical drivers of the 11q13 amplicon in head and neck SCC.",{"name":119,"@type":110,"acceptedAnswer":120},"How does CCND1 amplification influence tumorigenesis according to the study?",{"text":121,"@type":113},"CCND1 amplification drives the cell cycle in a CDK4/6/RB1-independent manner and may confer a novel dependency on RRM2.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335914,1790195358,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","ORAOV1, CCND1, and MIR548K Are the Driver Oncogenesof the 11q13 Amplicon in Squamous Cell Carcinoma  \nCline I. Mahieu1, Andrew G. Mancini2, Ellee P. Vikram1, Vicente Planells-Palop1, Nancy M. Joseph3, and Aaron D. Tward1  \nABSTRACT  \n◥  \n11q13 ampliﬁcation is a frequent event in human cancer and in particular in squamous cell carcinomas (SCC) . Despite almost invariably spanning 10 genes, it is unclear which genetic components of the amplicon are the key driver events in SCC. A combination of computational, in vitro, ex vivo, and in vivo models leveraging efﬁcient primary human keratinocyte genome editing by Cas9-RNP electroporation, identiﬁed ORAOV1, CCND1, and MIR548K as the critical drivers of the amplicon in head and neck SCC. CCND1 ampliﬁcation drives the cell cycle in a CDK4/6/RB1-independent fashion and may confer a novel dependency on RRM2 .  \nMIR548K contributes to epithelial–mesenchymal transition. Finally, we identify ORAOV1 as an oncogene that acts likely via its ability to modulate reactive oxygen species. Thus, the 11q13 amplicon drives SCC through at least three independent genetic elements and suggests therapeutic targets for this morbid and lethal disease.  \nImplications: This work demonstrates novel mechanisms and ways to target these mechanisms underlying the most common ampliﬁcation in squamous cell carcinoma, one of the most prevalent and deadly forms of human cancer.  \nIntroduction  \nCancer evolves through distinct types of mutations, including single-nucleotide variations, indels, chromosomal gains and losses, focal ampliﬁcations, and complex rearrangements. Among the most common chromosomal ampliﬁcations in cancer is the 11q13 ampliﬁcation. 11q13 ampliﬁcation occurs in approximately 6% of all tumors previously studied, making it the third most common ampliﬁcation across cancers, following MYC and PIK3CA ampliﬁcations (ref. 1; Supplementary Fig. S1a) .  \nSquamous cell carcinomas (SCC) are enriched for ampliﬁcation of 11q13 (1–4) . Ampliﬁcations of 11q13 tend to be an early event in SCC tumorigenesis (2–4) and co-occur alongside loss of function mutations in tumor suppressor genes such as TP53 and CDKN2A (5,6) . Although several studies have described a role for individual 11q13 genes in SSC tumorigenesis (5, 7), these studies have been limited by their focus on individual genes on the amplicon without consideration of the roles of other genes on the amplicon and the greater genetic context in which 11q13 ampliﬁcation occurs. In particular, the role of ORAOV1 (LTO1) has been incompletely explored. Thus, despite the high frequency of 11q13 ampliﬁcation, it still remains unclear which genes comprise the functional core of the 11q13 amplicon in SCC and through which mechanisms they contribute to SCC tumorigenesis.  \n1Department of Otolaryngology, Head and Neck Surgery, University of California San Francisco, San Francisco, Calfornia. 2MaxCyte, Inc., Gaithersburg, Maryland. 3Department of Pathology, University of California San Francisco, San Francisco, California.  \nCorresponding Author: Aaron D. Tward, University of California, San Francisco, 513 Parnassus Avenue, HSE 740, San Francisco, CA 94143 . E-mail: [Aaron.Tward@ucsf.edu](Aaron.Tward@ucsf.edu)  \nMol Cancer Res 2024;22:152–68  \ndoi: 10.1158/1541-7786 . MCR-23-0746  \nThis open access article is distributed under the Creative Commons AttributionNonCommercial-NoDerivatives 4 . 0 International (CC BY-NC-ND 4 . 0) license.  \n􀀁2023The Authors;Published by the American Association for Cancer Research  \nThe frequency of this CCND1 containing amplicon generated enthusiasm for the use ofCDK4/6 inhibitors, such as palbociclib, as potential therapeutics in SCC. This is based upon the assumption that CDK4 and/or CDK6 are critical downstream targets of ampliﬁed CCND1 in SCC. One phase II study of palbociclib in lung SCC (LSCC) patients with known ampliﬁcation of CCND1 failed to demonstrate signiﬁcant disease controlling activity (8) . A double-blind randomized plac","cbCaisQP3FaXIFGe","https://ap.wps.com/l/cbCaisQP3FaXIFGe","pdf",6338241,17,"English","# Introduction\n## 11q13 amplification in cancer and SCC\n## Rationale for identifying functional drivers in the amplicon\n# Models and experimental approach\n## Primary keratinocyte genome editing and HNSCC modeling\n# Key findings and mechanisms","[{\"question\":\"What event in cancer is emphasized in the study, and where is it common?\",\"answer\":\"The study focuses on 11q13 amplification, described as a frequent cancer event and particularly common in squamous cell carcinomas (SCC), including head and neck SCC.\"},{\"question\":\"Which genes are identified as the critical driver oncogenes of the 11q13 amplicon?\",\"answer\":\"The study identifies ORAOV1, CCND1, and MIR548K as the critical drivers of the 11q13 amplicon in head and neck SCC.\"},{\"question\":\"How does CCND1 amplification influence tumorigenesis according to the study?\",\"answer\":\"CCND1 amplification drives the cell cycle in a CDK4/6/RB1-independent manner and may confer a novel dependency on RRM2.\"}]","ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma | PDF",1790012816,43]